Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

NCT03236792 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

AL Amyloidosis

Interventions

DRUG: Ixazomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]